QDK — Integrated Continuous Glucose Monitoring System For Non-Intensive Diabetes Management Class II
Classification Details
- Product Code
- QDK
- Device Class
- Class II
- Regulation Number
- 862.1355
- Submission Type
- Review Panel
- CH
- Medical Specialty
- Clinical Chemistry
- Implant
- No
Definition
An integrated continuous glucose monitoring system for non-intensive diabetes management is intended to replace finger stick blood glucose testing for diabetes treatment decisions in persons with diabetes who do not have significant risk of severe hypoglycemia. The device also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating long-term therapy adjustments. The device is also intended to autonomously communicate with digitally connected devices. The device can be used alone or in conjunction with these digitally connected devices or services for the purpose of managing diabetes.
Recent 510(k) Clearances
| K-Number | Applicant | Device Name | Date |
|---|---|---|---|
| K203089 | dexcom | Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System | August 17, 2021 |
| K193642 | dexcom | Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System | January 29, 2020 |
| K192787 | dexcom | Dexcom G6 Glucose Program Continuous Glucose Monitoring (GCM) System | October 25, 2019 |
| K182041 | dexcom | Dexcom G6 Glucose Program Continuous Glucose Monitoring System | October 26, 2018 |